Lou Lange - Profile and Investment Details

Investor Profile

Lou Lange is a Venture Capital, Private Equity Firm, Micro VC, Investor based in Palo Alto, California, United States with a diverse investment portfolio that includes companies such as Indi Molecular, ICON Aircraft, CardioGen Sciences, Chimerix, CardioDx, Esperion Therapeutics, LiquidMThe Activity Exchange (AchieveMint), Signal Vine, Provade, Inc., Proteus Digital Health, OfferIQ, Carta Healthcare, RallyPoint, Welldoc, Freenome, Audentes Therapeutics, InCarda Therapeutics, Rapidscan Pharma Solutions, Unnatural Products, Maverix Biomics, Huiseoul, HealthTap, Tradeo, Arterys, Ooma, Mightier, ViewPoint Therapeutics, Aegis Surgical, Benefitter, Properly, Biomimedica, Profusa, Thunder, Mozio, Sensomics, Amygdala Neuroscience, ImmunoCellular Therapeutics, Outcomes4Me, Evidation Health, Lark, Womply, Twist Bioscience, Terra Bella, UniKey Technologies, Keepsafe, HighTower Advisors, Welkin Health, 1DocWay, 3T Biosciences, Synecor, Decent, Secure AI Labs, Reify Health, . Over time, Lou Lange has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Lou Lange is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Cybersecurity, Wellness, Women Founded, Apps, Healthcare Innovation, Life Science, Medical Technologies, Artificial Intelligence (AI), Information Technology (IT), Analytics, Internet of Things (IoT), Mobile, Technology, Software, Biotechnology, Medical Devices, Technical Support, Clinical Trials, FinTech, Hardware, Insurance, Logistics, Digital Health, Medical, Information Technology, B2B, Health Tech, Machine Learning, Personal Health, Healthcare Technology, DNA Synthesis may find it worthwhile to explore potential connections with Lou Lange, as their portfolio suggests a familiarity and interest in this area.

Understanding Lou Lange’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.